GlassScriptPhysician profile
Yelena Tsyba
NPI 1407083769
$1,524.78
in general payments reported to CMS, 2019-2025
17 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $146 · 2021: $253 · 2022: $474 · 2023: $84.56 · 2024: $101 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451 · Education: $16.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.28 |
| Education | $16.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $413.34 | 2022 | |
| Avion Pharmaceuticals | $192.65 | 2019-2021 | |
| Abbvie INC. | $165.56 | 2020-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $110.87 | 2025 | Slynd |
| Lupin INC. | $109.39 | 2019-2020 | |
| Evofem Biosciences, INC. | $96.09 | 2021-2022 | |
| Pfizer INC. | $73.15 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $72.02 | 2023-2024 | Myfembree |
| Biogen, INC. | $59.42 | 2025 | Zurzuvae |
| Millicent US INC | $47.55 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Exact Sciences Corporation | $37.43 | 2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $32.72 | 2021-2022 | |
| Astellas Pharma US INC | $29.31 | 2025 | Veozah |
| Shield Therapeutics INC | $22.77 | 2024 | |
| Vertical Pharmaceuticals, LLC | $21.30 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $21.16 | 2023 | Twirla |
| Coopersurgical, INC. | $20.05 | 2025 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yelena Tsyba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.